The longevity clinic network is adding California and Texas locations after a record-breaking Dallas launch signals rising demand.
The race to build the next generation of healthcare is gathering pace, and Humanaut Health is betting that more Americans want to invest in staying healthy before they become sick.
The physician-led longevity clinic network has announced plans to open new locations in Palm Desert, California, and San Antonio, Texas, following a standout launch in Dallas that saw more than 250 Founding Memberships sold during its first week [1]. According to the company, the strong early demand meant the Dallas clinic became cash flow positive within its first month, making it one of Humanaut Health’s most successful openings to date.
The expansion reflects a broader shift taking place across the longevity sector. Rather than waiting for illness to develop, growing numbers of consumers are looking for healthcare that focuses on prevention, performance and maintaining quality of life as they age.
“The response we’ve seen in Dallas reinforced what we’ve believed from the beginning: people are actively seeking a more proactive approach to their health,” said Jim Donnelly, co-founder and CEO of Humanaut Health. “When more than 200 people commit to a new healthcare model before the doors even open, it sends a powerful signal that consumers are ready for something different. Palm Desert and San Antonio represent the next step in our growth, expanding access to Humanaut’s progressive approach and our vision for a healthcare system built around helping people live healthier, longer lives.”
Founded in 2023, Humanaut Health has positioned itself within the growing longevity economy by combining extensive health testing with personalized care plans that evolve over time.
Every member begins with a detailed health assessment that looks at factors such as body composition, cardiovascular health, fitness levels and a wide range of biological markers. Rather than offering a one-size-fits-all program, clinicians use that information to build an individualized roadmap that is reviewed and adjusted throughout the year.
Beyond diagnostics, the clinics offer services spanning nutrition coaching, fitness support, recovery therapies, peptide treatments and other interventions that have become increasingly popular among longevity-focused consumers. Some of its more advanced offerings, including therapeutic plasma exchange, stem cell therapies and blood filtration procedures, sit at the frontier of preventive medicine, although many remain areas of active scientific research and discussion within the broader medical community.
Humanaut also offers an intensive personalized treatment program priced at $75,000, combining several of these therapies alongside ongoing testing and clinical supervision.
Expansion follows a familiar longevity playbook
The company’s latest announcement builds on steady growth since opening its flagship Austin clinic. Humanaut has since expanded into Palm Beach Gardens, Florida, and Dallas, with Palm Desert expected to open in fall 2026 on El Paseo, a luxury shopping district often called the “Rodeo Drive of the Desert.” The San Antonio location is scheduled to follow later this year, further strengthening the company’s presence across Texas.
For investors watching the longevity sector, the pace of expansion is notable not simply because another clinic chain is adding locations, but because it suggests demand may be moving beyond early adopters.
Longevity medicine has increasingly shifted from being associated with elite biohackers toward becoming a more structured healthcare category, where physician oversight, diagnostics and measurable health outcomes are becoming key differentiators.
Humanaut says its approach is producing measurable improvements for members, particularly among those with elevated metabolic and cardiovascular risk.
According to the company, 83% of members at risk of diabetes experienced lower average blood sugar levels, while 87% of high-risk members reduced ApoB, a marker associated with cardiovascular risk. It also reports meaningful cholesterol reductions among 68% of members.
While those figures are company-reported, they reflect one of the defining characteristics of the modern longevity industry: an increasing emphasis on tracking health through continuous data rather than relying solely on annual checkups.
The bigger picture for longevity
Humanaut Health’s rapid expansion arrives at a time when longevity is evolving from a niche wellness trend into an increasingly investable healthcare category. Clinics offering personalized diagnostics, preventive care, and health optimization are attracting growing consumer interest as people seek greater control over how they age.
For the longevity industry, the Dallas launch offers another signal that demand may be extending beyond coastal innovation hubs into mainstream markets. As more companies scale physician-led models and consumers become comfortable paying for proactive care, the sector is beginning to test whether longevity medicine can become a sustainable part of everyday healthcare – not just an aspirational lifestyle. That evolution will be closely watched by investors, healthcare providers and innovators alike, as the business of extending healthspan continues to mature alongside the science.
